Psychedelics Today Podcast

In this episode, Court Wing (Founder of REMAP Therapeutics) joins Joe in interviewing Joel Castellanos, MD, and Timothy Furnish, MD, of UC San Diego's Psychedelics and Health Research Initiative (PHRI). 

www.psychedelicstoday.com

In this episode, Kyle interviews Dr. Steven Radowitz: Medical Director at Nushama, a wellness center in New York City primarily offering IV ketamine, with a strong focus on allowing an undisturbed, explorational journey.

www.psychedelicstoday.com

In this episode, Joe interviews David Bronner, CEO of Dr. Bronner’s, a top-selling natural soap brand. They discuss Colorado Proposition 122, a ballot initiative that would decriminalize several natural medicines in the state. 

www.psychedelicstoday.com

In this episode, Joe interviews Dr. Rochelle Hines, Ph.D. and Dr. Dustin Hines, Ph.D.: Co-Founders of Tesselate Therapeutics, which is focused on the development and testing of novel psychedelic molecules. 

www.psychedelicstoday.com

In this episode, Kyle interviews Dr. Jennifer Montjoy: psychiatric nurse practitioner specializing in ketamine-assisted psychotherapy, and Medical & Research Director at TRIPP; a 501(c)(3) psychedelic training organization.

www.psychedelicstoday.com

In this episode, David interviews Jamie Wheal: author of Recapture the Rapture: Rethinking God, Sex and Death In a World That's Lost Its Mind, and Founder of performance research/training organization: the Flow Genome Project.

www.psychedelicstoday.com

In this episode, Joe interviews Reggie Harris: Founder of Oakland Hyphae, which organizes events like the Hyphae Cup (previously the Psilocybin Cup), and performs psilocybin potency testing through Hyphae Labs. 

www.psychedelicstoday.com

In this episode, Victoria interviews Cory Firth: Chief Storyteller at the Nikean Foundation, a non-profit passionate about storytelling, and aiming to build the largest collection of transformational psychedelic stories online.

www.psychedelicstoday.com

In this episode, Joe interviews Jason Slot, Ph.D.: Associate Professor of Mycology and Evolutionary Genomics at Ohio State University. Slot discusses mushroom reproduction and what the science of evolutionary genomics entails.

www.psychedelicstoday.com

In this episode, Joe interviews Stephanie Wang: Founder and CEO of KA! Empathogenics, which has created the first-ever supplement chew with the primary ingredient of kanna, a natural succulent plant with effects similar to MDMA.

www.psychedelicstoday.com

In this episode, Joe interviews Sawyer Hurwitz: filmmaker and augmented reality collage artist who releases art under the name, Psychotronic Solutions. He also directed our new TV show, "Psychedelics Tonight" airing on ALTRD.TV.

www.psychedelicstoday.com

In this episode, Kyle interviews Clinical Psychologist and Founder of the Psychedelic Society of Vermont, Dr. Rick Barnett, from a live event in Burlington, VT this past June. They discuss psychedelics' various contexts of use.

www.psychedelicstoday.com

In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule. 

www.psychedelicstoday.com

In this episode, Joe interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups. They discuss investment, IP, the psychedelic crash, ibogaine, and more.

www.psychedelicstoday.com

In this episode, David interviews Founder of the People of Color Psychedelic Collective: Ifetayo Harvey. She talks about the racism of the drug war, the importance of caregiving, and what we can do collectively to make change.

www.psychedelicstoday.com

In this episode, Joe interviews Laura Guzmán-Dávalos: 40-year veteran mycologist at the University of Guadalajara, Mexico; and daughter of Gaston Guzman, who most consider the world authority on the genus, Psilocybe. 

www.psychedelicstoday.com

In this episode, Kyle interviews Doctors James Fadiman, Sam Gandy; and David Luke. They discuss Fadiman's past research and Gandy and Luke's new paper, "Psychedelics as potential catalysts of scientific creativity and insight."

www.psychedelicstoday.com

In this episode, Joe interviews Alex Enchin & Ian-Michael Hébert, MA; Co-Founders of HOLOS, a company building hospitality wellness centers with a strong focus on community, reconnection to nature, and a return to wholeness.

www.psychedelicstoday.com

In this episode, Joe interviews Seth Rosenberg: Washington DC-based mycologist and anti-drug war advocate who worked on DC's decriminalization Initiative 81, and who was presumably arrested for purchasing legal plants online. 

www.psychedelicstoday.com

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. 

www.psychedelicstoday.com